Clinical Trial Update: Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating local therapy for oligorecurrent and oligometastatic esophageal squamous cell carcinoma; status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED